Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 82.74

-1.3%

Dec 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (363)	8/28/2003 11:44:04 AM
From: Jibacoa	Read Replies (1) of 3722

AVII Is trying to close above its initial resistance at the 5.10 level. It needs to close above that in order to test the more important resistance from the 5.70 to th 6.25 level.<g> It is been helped today by the comments yesterday of Dr.Benjamin, a "Biotechnology Analyst" at Rodman and Renshaw, in an interview by the Wall Street Trancript. Among his comments: "AVI BioPharma is an antisense play. They have data coming up in the second half that not only address large unmet needs in cardiovascular disease, but also in infectious diseases such as West Nile Virus and Severe Acute Respiratory Syndrome (SARS)". biz.yahoo.com Although AVII's revenues are down, they were able to cut their loss by 62% in the last 6 months, they have close to $1 in cash/share and there is a short position about 11% of the float. siliconinvestor.com siliconinvestor.com The increase in OBV since April can bee seen best on the longer term chart. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next